PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
1.000
-0.010 (-0.99%)
At close: Nov 22, 2024, 4:00 PM
1.040
+0.040 (4.00%)
After-hours: Nov 22, 2024, 6:01 PM EST
PAVmed Employees
PAVmed had 107 employees as of December 31, 2023. The number of employees decreased by 17 or -13.71% compared to the previous year.
Employees
107
Change (1Y)
-17
Growth (1Y)
-13.71%
Revenue / Employee
$37,701
Profits / Employee
$137,523
Market Cap
10.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
MSP Recovery | 88 |
Turnstone Biologics | 80 |
Apollomics | 45 |
Vaccinex | 40 |
Dominari Holdings | 28 |
Elevai Labs | 18 |
QT Imaging Holdings | 14 |
Alterity Therapeutics | 10 |
PAVM News
- 3 days ago - Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test - PRNewsWire
- 5 days ago - Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PRNewsWire
- 8 days ago - PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - PAVmed Provides Business Update and Third Quarter 2024 Financial Results - PRNewsWire
- 10 days ago - Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results - PRNewsWire
- 16 days ago - Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication - PRNewsWire
- 18 days ago - Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers - PRNewsWire
- 23 days ago - PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024 - PRNewsWire